Rifaximin is a gastrointestinal-selective antibiotic for colitis and cancer research
**Background** Inflammatory bowel diseases, such as colitis, are characterized by chronic inflammation of the gastrointestinal tract, often involving an imbalance in gut microbiota and the translocation of bacteria. Managing these…